Epigenetic regulation of BDNF gene in response to stress.
Neuronal plasticity induced by changes in synaptic morphology and function is well known to play a pivotal role in leaning and memory as well as adaptation to stress. It is suggested that these plastic changes are due to orchestration of alterations in gene expression in the brain. Recent advances in molecular biology have provided evidence that epigenetic mechanisms, such as DNA methylation and histone modification, are crucial to gene transcription in the mammalian brain. Our research group has recently investigated the involvement of histone actylation at the promoter of the brain-derived neurotrophic factor (BDNF) gene in stress-induced reduction in BDNF, as well as in fear conditioning-induced enhancement of BDNF, in the rat hippocampus. The results of the stress study demonstrated that single-immobilization stress significantly reduced the levels of total, exon I, and exon IV BDNF mRNA, and also significantly reduced acetylation levels of histone H3, but not H4, at the promoter of exons I, IV, and VI. The results of the fear conditioning study showed that footshock stress significantly increased the levels of total, exon I, and exon IV BDNF mRNA, with significantly increased acetylation levels of both histone H3 and H4, at the promoter of exons I and IV, followed by enhanced freezing to fear-context exposure. These findings suggest that changes in BDNF transcription in the rat hippocampus in response to stressful stimuli are, at least in part, regulated by histone acetylation status.
Department of Psychiatry and Neurosciences, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Manabu
M
Fuchikami
Shigeto
S
Yamamoto
Shigeru
S
Morinobu
Shiro
S
Takei
Shigeto
S
Yamawaki
Mol Pharmacol. 2007 Aug;72(2):350-8
17456785
Biol Psychol. 2006 Jul;73(1):61-71
16476517
Cell Death Differ. 2006 Apr;13(4):539-50
16167067
Biol Psychiatry. 2006 Aug 15;60(4):376-82
16919525
J Neurosci. 2002 Oct 1;22(19):8422-8
12351716
Neuropsychopharmacology. 2007 Jul;32(7):1504-19
17164818
Nat Neurosci. 2004 Aug;7(8):847-54
15220929
Biochem Pharmacol. 2006 Nov 30;72(11):1563-9
16836980
Physiol Rev. 2007 Jul;87(3):873-904
17615391
Psychoneuroendocrinology. 1997 Aug;22(6):443-53
9364622
Neurosci Res. 1997 Jun;28(2):103-10
9220467
Nat Neurosci. 2000 Jun;3(6):533-5
10816306
Ann N Y Acad Sci. 2003 Dec;1008:112-21
14998877
Neuron. 2007 Oct 4;56(1):19-32
17920012
J Neurosci. 2004 Sep 8;24(36):7958-63
15356210
Biol Psychiatry. 2006 Aug 15;60(4):337-43
16712801
Nat Rev Neurosci. 2005 Feb;6(2):108-18
15654323
Learn Mem. 2004 Nov-Dec;11(6):727-31
15537738
Brain Res Mol Brain Res. 1999 Jul 23;71(1):11-22
10407182
Eur J Neurosci. 1994 Apr 1;6(4):587-96
8025713
Neuron. 2004 Jun 24;42(6):961-72
15207240
J Neurosci. 1995 Mar;15(3 Pt 1):1768-77
7891134
Biol Psychiatry. 2006 Jun 15;59(12):1116-27
16631126
Brain Res Mol Brain Res. 1998 Oct 30;61(1-2):147-53
9795193
Learn Mem. 2007 Apr 06;14(4):268-76
17522015
J Neurosci. 1995 Nov;15(11):7539-47
7472505
J Biol Chem. 2004 Sep 24;279(39):40545-59
15273246
J Neuroendocrinol. 1999 Jan;11(1):11-7
9918224
Brain Res. 2006 Jan 5;1067(1):1-12
16376315
J Neurosci. 2008 Oct 15;28(42):10576-86
18923034
Neurobiol Learn Mem. 2008 May;89(4):599-603
17881251
J Neurosci. 2004 Jun 16;24(24):5603-10
15201333
Annu Rev Clin Psychol. 2005;1:293-319
17716090
Learn Mem. 2006 May-Jun;13(3):241-4
16741277
Nat Neurosci. 2006 Apr;9(4):519-25
16501568